Selecta Biosciences, Inc.
SELB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,902 | $15,886 | -$17,710 | -$35,372 |
| Dep. & Amort. | $606 | $589 | $1,156 | $580 |
| Deferred Tax | $0 | $0 | $0 | $9,675 |
| Stock-Based Comp. | $2,590 | $3,279 | $2,508 | -$1,798 |
| Change in WC | $8,590 | $7,082 | $0 | -$8,881 |
| Other Non-Cash | $8,516 | -$44,357 | -$9,062 | $39,997 |
| Operating Cash Flow | -$15,600 | -$17,521 | -$23,108 | $4,201 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,292 | -$2,595 | -$1,075 | -$8,951 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$28,254 |
| Other Inv. Act. | $0 | $0 | $0 | $351 |
| Investing Cash Flow | -$1,292 | -$2,595 | -$1,075 | -$36,854 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $271 | $0 | $0 | $40,000 |
| Stock Repurch. | $0 | $0 | $0 | -$149 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$38 | $60 | -$8,025 | $195,654 |
| Financing Cash Flow | -$38 | $60 | -$8,025 | $195,654 |
| Forex Effect | -$10 | $12 | $32 | $48 |
| Net Chg. in Cash | -$16,940 | -$20,044 | -$32,176 | $133,299 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $162,059 | $182,103 | $214,279 | $80,980 |
| End Cash | $145,119 | $162,059 | $182,103 | $214,279 |
| Free Cash Flow | -$16,892 | -$20,116 | -$24,183 | -$4,750 |